Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Did it take that long, or did past management drop the ball and current management actually got it done?
So what is the back-up plan if FDA says No after the 60 days?
Jack - I would say unbelievable, but I would put nothing past our previous management! :(
Are they really still paying him?
According to this release they still can't market this in the US, though hopefully that will be remedied soon. So was this an "oversight" by previous management?
Although Medizone will be required to apply for a separate approval in each country...
With respect to future marketing endeavors in North America, third-party certification of electrical products is mandated by law; without such certification, marketing would not be permitted.
I don't see the material being discussed on cc on the website yet.
>> Materials to support the call will be made available on the website prior to the start of the call.
Food handling patent
Medizone International Expands Patent Coverage for AsepticSure
AsepticSure receives US Patent for Food-Handling Facility Disinfectant
June 20, 2017 – Medizone International, Inc. (OTCQB: MZEI) (Kalamazoo, MI) today announces the United States Patent and Trademark Office has agreed to grant a patent for Food-Handling Facility Disinfectant for AsepticSure (US Patent 9,616,144).
“Our team our researchers continues to demonstrate the broad utility of AsepticSure in a number of commercial applications,” commented David A. Esposito, Chairman of the Board and interim CEO of Medizone International. “The granting of this patent helps to strengthen our intellectual property to ensure protected access to these large market opportunities.”
The food services industry is a significant market opportunity for the Company. The patent for Food-Handling Facility Disinfectant adds to a strong portfolio of IP covering hospital disinfection, bioterrorism counter measures, and sports equipment and facility disinfection.
My take on CC - Real progress (with concrete results) would have been announced in a PR. So the best we can hope for is to hear that things are moving the right direction; which I think they are.
So while I very much appreciate that they are updating shareholders and keeping us informed I don't expect anything earth-shattering tomorrow.
Go - The $49 is to test the house to see if you need the cleaning. No mention of cleaning costs, but if it takes 4 days must be a nice sum.
"Find out if your home is free from meth
$49 for a peace of mind? We’d say yes."
BenK - So that website, and marketing plan, is an active idea being pursued by Medizone?
NSD - Maybe no market research, but they seems to have active leads with specific companies. I have to give current management the benefit of the doubt. They have a good track record and deserve the time to develop this technology and the markets.
"The company is actively pursuing a wide range of business development initiatives with the major publicly traded companies that are leading innovation in the death care industry in the United States."
The major difference now is that they now have clearance to actually sell it because they don't need FDA for these markets.
Unfortunately the fact that they are developing these ancillary markets might mean that they don't expect FDA approval anytime soon. I'm sure the irony is not lost on long-time shareholders. Medizone went off in this direction 9 years ago to get around the FDA and get to market quickly. 9 years later we are waiting for FDA.
Green - I'm hoping for something before that. The last cc was scheduled 2 or 3 days in advance - this one was 2 weeks. My optimistic side is whispering that they gave the long-lead time in order to finalize something before the call.
Go - You might be "ready to leave the station", but I'm on the launch pad going to the moon :)
>> we are all more than ready to leave the station
I also picked up some more shares below .07 several weeks ago. I keep on telling myself I'm done adding, but unfortunately we keep on getting these buying opportunities. Hope this will be the last time ...
Go - Now that we are marketing to dead people the sky (or moon) is the limit!! :)
>> something in the cards?
Green - Currently healthier bodies require FDA approval - dead bodies don't!
>> I think they need to stick to the healthier bodies that need some kind of healthcare.
I disagree - I give them much more credit. This tells me something is going on right now. Obviously the industry leaders think there is something here for them.
The company is actively pursuing a wide range of business development initiatives with the major publicly traded companies
Funny - Had Ed released this I would have rolled my eyes and wished he would stay focused. Somehow coming from this management team it feels completely different.
As someone mentioned recently for certain markets there should be no need for FDA approval. Perhaps this is an example of that strategy and they can start selling this market without FDA approval.
"We look forward to transferring our current research initiatives into immediate commercial opportunities for AsepticSure."
Why are you depressed? You should consider yourself lucky. I'm 17 years and blowing bubbles!
Go - I don't see it mentioned that he was being added to the BOD.
I knew the name sounded familiar. Hopefully he will have more success this time around!
I don't disagree - still very surprised at the quality of their website.
>> Another piece in the puzzle for MZEI and David Esposito....and very good news....
Very strange - They link to a domain that is for sale. There is no information on the principals of the company or any of their existing clients.
Yet the PR says they have long-standing relationships with some of the largest health systems and group purchasing organizations in the world.
On the surface looks like an Ed move, but I have to assume that there is more here than what their website shows. Though it is surprising a marketing company would have a such a bad website.
Innovasource
Consumer Products
PROXI is a full line of home care, personal care, and oral care products that clean with the powerfully simple ingredient of hydrogen peroxide. To visit the PROXI website, please click here.
Could be Ed was told that, but why do I suspect had DE been the CEO for the past 3 years he would have found out several years ago that the FDA really did need to approve.
New Board Member
http://www.medizoneint.com/2017/04/06/medizone-international-expands-board-of-directors-to-support-executing-on-the-launch-of-asepticsure-in-key-global-markets/
Medizone International Expands Board of Directors to Support Executing on the Launch of AsepticSure in Key Global Markets
New Medizone Board Member, Dwayne Montgomery, will play critical role in the company's growth plans.
Medizone International, Inc. (MZEI:OB MZEI:QB) announces the addition of Dwayne Montgomery to the Board of Directors. Medizone makes this move in support of expanding the commercial experience of the team and accelerating the growth of the company's AsepticSure® hospital disinfection system.
"As Medizone International continues to move forward with our growth plans, it is important that we continue to build our team with talented commercial leaders to help the organization reach its potential in establishing the AsepticSure system as the new gold standard for disinfection across a wide range of commercial applications," commented David A. Esposito, Chairman of the Board and interim CEO of Medizone International. "As we execute on our global commercial plans for the AsepticSure system, we are pleased to announce that Dwayne Montgomery has joined our Board of Directors to help support our commercial strategy and business development initiatives."
Mr. Montgomery brings a tremendous amount of global commercial experience as a senior executive in high growth segments of healthcare to his role on the board. His accomplished career spans 25+ years and is documented with deep knowledge and success in medical device and biotech executive management. His commercial expertise is backed with a proven track record of operational performance as well as business development success through mergers and acquisitions with both domestic and international organizations.
Mr. Montgomery has led companies through significant growth periods with varying size, including large, mid-cap, and start-up ventures. Most recently, Mr. Montgomery served as the President and Chief Executive Officer for Osiris Therapeutics, Inc., a market leading company focused on advancing regenerative medicine. He was also a member of Osiris Therapeutics' Board of Directors. Most notably, Mr. Montgomery orchestrated Osiris Therapeutics' strategic partnerships with both Arthrex and Stryker, leaders in their respective healthcare segments. Mr. Montgomery graduated with a Bachelor of Science degree in chemistry from the University of North Alabama and attained a Master of Business Administration degree from Belmont University.
Mr. Montgomery commented on joining the Board of Directors, "I am extremely honored to be joining the Board of Directors for Medizone International as we execute on our growth plans. I am impressed with this compelling and disruptive technology as well as its unique value-proposition. The AsepticSure system has the potential to be game-changing technology to address a significant unmet need in the market for more effective disinfection systems for hospitals, long-term care facilities, and a number of applications beyond the healthcare marketplace. I look forward to being a very active member of the Board of Directors to support the team in reaching our full commercial potential."
Green - Not sure why you think there are trials going on or even imminent. The impression I had from the cc was that were not close to finalizing anything. If you are referring to Ed's claim of testing at the beginning of the year - I think it is quite obvious that was in Ed's imagination rather than anything real.
I agree we are in good hands - that doesn't automatically mean he can overcome the issues that prevented Ed from being successful. Obviously he is a tremendous upgrade on previous management but the jury is still out if Asepticsure can make it out of the lab into the real world - hence the share price of .12
It is under $10,000 worth of stock so I wouldn't exactly call it "all the selling".
That being said the longer it takes for us to hear about Hospital trials/sales the more people will start to wonder "Was it really all Ed's fault, or is there really an issue getting hospitals to buy into Asepticsure that even DE can't overcome".
Finally some press coverage - if you speak Vietnamese :)
diendan.raovat.vn/tin-rao-vat/sua-chua-dien-thoai-oppo-tot.199024/
Hi John :)
Just shows how desperate some people are for news. Hopefully that thirst will be satisfied soon with real news.
Can you tell us why we have received no attention from the press and what is being done to address that?
This was published by Pentony in 2010!! This website just took an old posting and republished it
StockGuru Blog- Medizone (MZEI)
Posted on March 10, 2010 by admin
Read more at http://www2.thestockmarketwatch.com/newsletters/2010/03/10/stockguru-blog-medizone-mzei/#wMIDloJ87DgleZgK.99
Medizone International announced unprecedented success in being able to predictably achieve 6 log (99.9999%) kill rates for the causative agents of Hospital Acquired Infections (HAIs) represented with AsepticSure™. Medizone will build four highly instrumented prototype units for use in its hospital program.
Read more at http://www2.thestockmarketwatch.com/newsletters/2010/03/10/stockguru-blog-medizone-mzei/#wMIDloJ87DgleZgK.99
I don't recall that it was.
I'm still surprised as to the volume and share price since he took over. If you believed it was only Ed's incompetence that was preventing sales you would think that we would have seen a greater reaction to the news of a new CEO.
So what are the reasons for the current malaise? Take your pick or add another one:
Ed damaged Medizone's reputation enough that people are skeptical of anything Medizone until proven otherwise.
There are real issues in getting hospitals to buy Asepticsure ( See Cananda etc..)
People aren't convinced an interim (and most likely part-time) CEO, no matter how qualified, can get the job done.
Anyone have a theory why we haven't received a single mention in the press over the past 3-4 years?
I wouldn't call it a bust. It was very nice to hear a professional presentation of the current state of affairs and what their plan for the future is. It is true there was no new exciting news coming out of the call but I didn't really expect them to announce news on the call.
He did avoid the elephant in the room - how come there have been no sales to date?
I sent this question which I didn't feel was really answered on the call
"We have had regulatory approval in Canada for 3-4 years. US for 3 months. There have been no sales to date. What has been the major obstacles to closing sales and how will you address/overcome those issues going forward?"
I had assumed Ed left voluntarily, but if that was the case he would/should have been on the call introducing Esposito. Looks like he was pushed out.
Go - My take - There haven't been any and none are currently scheduled. They are working in that direction with what they are calling PEP - Product Evaluation Program.
Mea Culpa - I had predicted a while back that the stock would double overnight on news that Ed was leaving - obviously I was wrong. So I'm a little red-faced, but still very happy!!
Too bad it took 3 years to get him on board, but it is indeed very exciting.
Mr. Esposito is going to take questions during the call - nice to have a confident leader at the helm!!
Slides are posted. Wow - they said it would be there by 4PM and they are - how refreshing!!